We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current OXBOF market cap is 17.89M. The company's latest EPS is GBP -0.0061 and P/E is -0.84.
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 946k | 459k | 343k | 505k | 1.34M |
| Operating Income | -3.72M | -4.99M | -7.51M | -8.6M | -10.17M |
| Net Income | -2.8M | -4.35M | -6.68M | -6.71M | -10.83M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 18.79M | 14.93M | 15.38M | 11.34M | 16.13M |
| Total Liabilities | 1.2M | 1.77M | 8.69M | 8.76M | 10.07M |
| Total Equity | 17.59M | 13.16M | 6.69M | 2.59M | 6.06M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -2.27M | -3.4M | -5.92M | -5.18M | -8.29M |
| Investing | -11.19M | 4.58M | 2.83M | 1.25M | -620k |
| Financing | 236k | -181k | -804k | 2.56M | 13.21M |
| Market Cap | 17.89M |
| Price to Earnings Ratio | -0.84 |
| Price to Sales Ratio | 7.29 |
| Price to Cash Ratio | 1.76 |
| Price to Book Ratio | 1.51 |
| Dividend Yield | - |
| Shares Outstanding | 1.79B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -91.94% |
| 52 Week High | 0.15 |
| 52 Week Low | 0.01 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Oxford Biodynamics PLC (PK) |
| Address |
3140 rowan place oxford OX4 2WB |
| Website | https://www.oxfordbiodynamics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
